Cite
HARVARD Citation
Nagasawa, S. et al. (n.d.). 639PVolume reduction rate of the primary tumor of esophageal squamous cell carcinoma after neoadjuvant chemotherapy: Could this measurement be a surrogate end point for survival before surgery?. Annals of oncology. p. . [Online].